TNFRSF11B and osteoporosis: Osteoprotegerin‐deficient mice develop both premature and severe osteoporosis as well as arterial calcifications,27 whilst increased serum osteoprotegerin concentrations in humans are associated with adverse cardiovascular outcomes.28, 29, 30, 31, 32